Acute hypotension is an important complication of hemodialysis, but the underlying mechanisms remain poorly understood. Because hemorrhage-induced hypovolemia can trigger a sudden decrease in sympathetic activity resulting in bradycardia and vasodilation, we hypothesized that hemodialysis-induced hypovolemia also can trigger the same type of vasodepressor reaction, which would exacerbate the volume-dependent fall in blood pressure. We therefore measured blood pressure, vascular resistance, and sympathetic nerve activity (intraneural microelectrodes) during sessions of maintenance hemodialysis in 7 patients with and 16 patients without a history of hemodialysis-induced hypotension. During hemodialysis, blood pressure at first remained unchanged as calf resistance increased in both hypotension-resistant (from 37±4 to 49±5 U, P < 0.05) and hypotension-prone (from 42±6 to 66±12 U, P < 0.05) patients; sympathetic activity increased comparably in the subset of patients in whom it could be measured. With continued hemodialysis, calf resistance and sympathetic activity increased further in the hypotension-resistant patients, but in the hypotensionprone patients the precipitous decrease in blood pressure was accompanied by decreases in sympathetic activity, vascular resistance, and heart rate as well as symptoms of vasodepressor syncope. On an interdialysis day, both groups of patients increased vascular resistance normally during unloading ofcardiopulmonary baroreceptors with lower body negative pressure and increased heart rate normally during unloading of arterial baroreceptors with infusion of nitroprusside. These findings indicate that in a group of hemodialysis patients without diabetes or other conditions known to impair autonomic reflexes, hemodialysis-induced hypotension is not caused by chronic uremic impairment in arterial or cardiopulmonary baroreflexes but rather by acute, paradoxical withdrawal of sympathetic vasoconstrictor drive producing vasodepressor syncope. (J. Clin.
Introduction
Acute hypotension is an important complication ofhemodialysis, occurring in up to one-third of chronic dialysis patients (1) (2) (3) (4) . Although these hypotensive events often require aggressive resuscitative measures and premature termination of hemodialysis, the underlying mechanisms causing this episodic hypotension remain poorly understood.
One hypothesis is that hemodialysis-induced hypotension is a manifestation of uremic autonomic neuropathy, a form of chronic autonomic insufficiency caused by uremic poisoning of the baroreceptors (4) (5) (6) (7) (8) (9) . Although this hypothesis is widely acclaimed, a causal relationship between impaired baroreflexes and dialysis-induced hypotension has not been established (10, 11) .
Whereas hypotensive states typically lead to reflex sympathetic activation and vasoconstriction ( 12) , hemorrhagic hypotension can lead to sudden, paradoxical withdrawal of sympathetic drive, causing reflex vasodilation and bradycardia-a vasodepressor reaction that exacerbates the volume-dependent fall in blood pressure (13) (14) (15) . We therefore hypothesized that the hypovolemia that accompanies hemodialysis also might trigger the abrupt withdrawal of sympathetic vasoconstrictor drive, producing an acute, rather than chronic, form of autonomic insufficiency.
To test this new hypothesis, we measured muscle sympathetic nerve activity (intraneural microelectrodes) and regional vascular resistance during maintenance hemodialysis in patients with and without a history of dialysis-induced hypotension. To test the more traditional hypothesis linking dialysis-induced hypotension to chronic uremic poisoning ofbaroreceptors, we examined arterial and cardiopulmonary baroreflexes on an interdialysis day in the same patients.
Methods

Subjects
The study comprised 23 patients with end-stage renal failure on thriceweekly maintenance hemodialysis of 3-4 h duration and 8 healthy control subjects. Patients were studied at the chronic hemodialysis centers and the human neurophysiology laboratories of Parkland Memorial Hospital, Dallas, TX, and the Cleveland Clinic Foundation, Cleveland, OH. The protocol was approved by the Institutional Review Boards at both facilities and all subjects provided written informed consent before participation.
Based on their blood pressure response during hemodialysis, the patients were prospectively divided into two groups: 7 "hypotension-analgesic-related renal failure (n = 2), and Alport's syndrome (n = 1). Patients with a history or physical examination indicative of diabetes mellitus, coronary artery disease, congestive heart failure, cardiac arrhythmias, volume overload, alcohol abuse, peripheral neuropathy, or other serious systemic illness were excluded from the study. One-halfof our patients were not receiving antihypertensive medications. In those who were receiving antihypertensive medications, these medications were discontinued 48 h before study, with the exception offive patients in whom it was deemed unsafe to do so. These five patients included two hypotension-prone (taking captopril and metoprolol or captopril, metoprolol, and nifedipine) and three hypotension-resistant (taking captopril and nifedipine, labetolol and nifedipine, or atenolol).
Routine hemodialysis procedures were followed for each patient according to their individual prescriptions. All patients were dialyzed with volumetric control utilizing Fresenius (Feratromics Inc., Concord, CA) model A 20008E machines. Dialysis was performed with cellulose acetate (CDAK 135) dialyzers with blood flow rates ranging from 300 to 400 ml/mmin, dialysate flow of 500 ml/mmin, and ultrafiltration rate varying according to prescription. The dialysate composition was as follows: Na' 140 meq/liter, HCO-35 meq/liter, K+ 2.0 meq/ liter, Cl-104 meq/liter, Ca" 3.0 meq/liter, Mg"+ 0.75 meq/liter, dextrose 200 mg/dl. Heparinization was achieved with 5,000 units intravenous bolus followed by 500 u/h intermittent intravenous bolus.
General procedures
All experiments were performed with the subjects in the supine position. The studies were performed in a quiet area of the hemodialysis center separated from the other patients for the first two protocols and in the human neurophysiology laboratory for the latter three protocols. Heart rate (electrocardiography), blood pressure (Finapres, Ohmeda), and efferent muscle sympathetic nerve activity were recorded continuously; calfblood flow (plethysmography) was recorded once every 15 s, and all data were stored on a TEAC R-7 1 tape recorder, then converted to a digital signal with Computerscope software (R. C. Electronics, Goleta, CA) and also stored on an IBM AT personal computer. Data were transcribed from FM tape or from computer disk to hard copy using a model ES1000 electrostatic recorder (Gould, Inc., Oxnard, CA).
Recording ofsympathetic nerve discharge
Multiunit recordings ofpostganglionic sympathetic nerve activity were obtained with unipolar tungsten microelectrodes inserted selectively into muscle nerve fascicles ofthe peroneal nerve posterior to the fibular head according to the technique of Vallbo et al. ( 16) . Briefly, the neural signals were amplified 20,000-50,000 times, filtered (bandwidth, 700-2,000 Hz), rectified, and integrated (time constant, 0.1 s) to obtain a mean voltage display ofsympathetic activity. A recording of sympathetic activity was considered acceptable when the neurograms revealed spontaneous, pulse-synchronous bursts of neural activity, with the largest bursts showing a minimal signal-to-noise ratio of 3:1. In each experiment, we documented that we were recording sympathetic outflow to skeletal muscle by demonstrating that the neural activity had no response to arousal stimuli (loud noise or skin pinch) but had a characteristic cardiac rhythmicity (i.e., the interburst interval was equal to or a multiple of the cardiac cycle length).
Sympathetic bursts were detected by inspection of the filtered and mean voltage neurograms. A deflection on the mean voltage display was counted as a burst if it had a minimal signal-to-noise ratio of 2:1. The interobserver and intraobserver variabilities in identifying bursts are < 10% and < 5%, respectively ( 17) . Inadvertent contraction of the leg muscles adjacent to the recording electrode produces electromyographic artifacts that are easily distinguished from sympathetic bursts; neurograms that revealed such artifacts were excluded from analysis.
Nerve traffic was measured as the number of bursts of sympathetic activity per minute, an index of the frequency of sympathetic discharge, and as the burst frequency times mean burst amplitude, an index of total or integrated nerve traffic.
Measurement ofregional bloodflow
While recording sympathetic outflow to calf muscles in one leg, we simultaneously measured calf blood flow in the contralateral leg using venous-occlusion plethysmography ( 18 ) . The calf was elevated above the level ofthe right atrium to collapse the veins. The circulation to the foot was arrested during the blood-flow determinations, which were performed at 15-s intervals. Calf vascular resistance was calculated as the mean arterial pressure (one third ofthe pulse pressure plus diastolic pressure) in millimeters of mercury divided by calfblood flow in milliliters per minute per 100 ml oftissue. The lower body negative pressure protocol (protocol 3) necessitated measuring blood flow in the forearm (outside of the negative pressure chamber) rather than in the calf (which is inside the negative pressure chamber). Forearm blood flow and vascular resistance data were obtained using the same plethysmographic technique.
Echocardiographic measurements ofleft ventricular dimensions
Left ventricular end-diastolic and end-systolic dimensions were measured by two-dimensional echocardiography using a parasternal short axis view according to the criteria ofthe American Society ofEchocardiography ( 19) .
Lower body negative pressure
On the interdialysis day, subjects were brought to the human neurophysiology laboratory and placed in an airtight chamber to the level of the iliac crests. Venous pooling was produced by application ofgraded lower body negative pressure at -10 and -20 mmHg. The pressure inside of the chamber was measured with a Statham pressure transducer (Gould, Inc.). Lower body negative pressure at -10 and -20 mmHg is thought to unload primarily low pressure cardiopulmonary (rather than arterial) baroreceptors, since central venous pressure falls but blood pressure, heart rate, and dP/dt are unchanged (20) .
Determination ofplasma norepinephrine and epinephrine concentrations We collected samples of blood from the patients from the dialysis access to the forearm fistula ("patient arterial, dialyzer venous"). Samples were collected in prechilled tubes treated with heparin and promptly centrifuged at 4VC. The samples were assayed by radioenzymatic assay by courtesy of Dr. E. L. Bravo, Cleveland Clinic Foundation. The assay is sensitive to 15 pg/ml.
Experimental protocols
Protocol 1: responses to conventional hemodialysis. To determine the neurocirculatory adjustments to hemodialysis in patients with and without dialysis-induced hypotension, we recorded blood pressure, heart rate, sympathetic nerve activity, and calf blood flow in 16 hypotension-resistant and 7 hypotension-prone chronic hemodialysis patients during sessions of maintenance hemodialysis and during the reinfusion of blood and normal saline (300 ml) after dialysis. Stable baseline measurements ( 15 min) were obtained before the initiation of hemodialysis. In a subset of five hypotension-resistant and five hypotension-prone patients, we performed two dimensional echocardiography and standard 12-lead electrocardiography throughout hemodialysis, paying particular attention to the period shortly preceding the onset of severe hypotension.
To determine whether stimulation ofcentral opiate receptors might contribute to the regulation of sympathetic nerve activity and blood pressure during hemodialysis, we planned to repeat this protocol while infusing the opiate receptor antagonist naloxone (0.5 mg/kg) during the last third ofthe hemodialysis session in a subset ofour hypotension prone patients. This protocol was performed in only one patient due to its clear lack of efficacy.
Protocol 2: responses to interventional hemodialysis maneuvers. To separate the effects of ultrafiltration from those of dialysis in causing episodic hypotension, in two of the hypotension-resistant and two of 1658 Converse et al.
the hypotension-prone patients we recorded heart rate, blood pressure, and calf blood flow during three separate dialysis maneuvers: (a) the usual hemodialysis procedure (combined ultrafiltration plus dialysis); (b) ultrafiltration alone; and (c) dialysis alone.
Protocol 3: responses to lower body negativepressure. In four hypotension-prone and four hypotension-resistant hemodialysis patients and eight healthy control subjects, we measured blood pressure, heart rate, and forearm blood flow during unloading ofmainly cardiopulmonary baroreceptors with graded lower body negative pressure at -10 and -20 mmHg for 2 min at each consecutive level.
Protocol 4: responses to intravenous nitroprusside. In four hypotension-prone and four hypotension-resistant hemodialysis patients and eight healthy control subjects, we measured increases in heart rate produced by nitroprusside-induced decreases in mean arterial pressure of -10 and -20 mmHg for 2 min at each consecutive dose. In each subject, arterial baroreflex gain was calculated as the increase in heart rate (beats/minute) per unit decrease in mean arterial pressure (mmHg).
Protocol 5: responses to the Valsalva maneuver. In a subset ofseven hypotension-resistant and one hypotension-prone hemodialysis patients, we compared responses of heart rate and muscle sympathetic nerve activity during performance of the Valsalva maneuver, which has been the standard test to assess baroreflex function in hemodialysis patients. This maneuver was performed by instructing subjects to exhale into a pressure manometer for 10 s. Subjects were instructed to perform only a mild expiratory effort so as not cause inadvertent contraction ofthe leg muscles which would dislodge the microelectrode. In each patient, we measured the peak decrease in cardiac cycle length and increase in muscle sympathetic activity during phases II and III (strain) and the peak increase in cardiac cycle length and decrease in muscle sympathetic activity during phase IV (release). Because the Valsalva maneuver perturbs multiple reflex mechanisms, no attempt was made to compare responses between subject groups.
Statistical analysis
Statistical analysis was performed using Student's unpaired t-test to compare baseline parameters between the two groups of dialysis patients. Group differences in responses during hemodialysis and during lower body negative pressure were compared using repeated measures analysis of variance with Dunnett's post hoc test for multiple comparisons. A P value of < 0.05 was considered to be statistically significant. Results are expressed as means±SE.
Results
The clinical characteristics and baseline values ofthe hemodialysis patients are shown in Table I . There were no statistical differences between hypotension-resistant and hypotensionprone patients.
Recordings of baseline muscle sympathetic nerve activity were obtained in 16 of the 23 hemodialysis patients. Owing to inadvertent leg movements ("restless legs syndrome") (21), stable recordings of sympathetic activity could be maintained for a substantial portion ofthe hemodialysis session in only six of these patients: in two hypotension-prone patients, sympathetic activity was recorded during almost the entire hemodialysis session, including the episodes of acute hypotension; in one hypotension-resistant patient, sympathetic activity was recorded during the entire hemodialysis session, including reinfusion of blood after hemodialysis; in two additional hypotension-resistant patients, sympathetic activity was recorded during the first third of the hemodialysis procedure, before the recordings deterioratedafand in a fourth hypotension-resistant patient, we could obtain an adequate recording of sympathetic activity only during the last third of hemodialysis and main- tained that recording during the period of volume reinfusion. Sympathetic activity was also recorded during performance of the Valsalva maneuver in eight patients and during spontaneous extrasystoles in nine patients.
Responses to hemodialysis. During the first two-thirds of hemodialysis, in both hypotension-resistant and hypotensionprone patients arterial pressure was well maintained as calf vascular resistance and sympathetic activity increased progressively, with little change in heart rate (Table II and Fig. I ). For comparable decreases in body weight during hemodialysis, calf vascular resistance increased comparably in the two groups. During the last third ofhemodialysis, however, the neurocirculatory responses differed markedly in the two groups. In the hypotension-resistant patients, vascular resistance and sympathetic activity continued to increase throughout the last third of hemodialysis (Table II and Fig. 1 ). During reinfusion of -300 ml of blood and saline after hemodialysis, calf resistance decreased promptly from 58±6 to 45±5 U (P < 0.05); sympathetic activity decreased proportionately in the two patients in whom it was measured. In the hypotension-prone patients, however, mean arterial pressure decreased by 17±7 mmHg and heart rate increased by 15±6 beats/min (P < 0.05 vs. baseline) shortly before the precipitous fall in blood pressure. As mean arterial pressure subsequently fell abruptly from 99±5 to 60±6 mmHg, sympathetic nerve activity, calf vascular resistance, and heart rate did not increase further but rather fell precipitously to baseline values (Table II and Fig. 1 ) as typical vasovagal symptoms developed in all ofthese patients. In one ofthese patients, these responses and symptoms were not attenuated and seemed to be exacer- bated by intravenous infusion ofthe opiate receptor antagonist naloxone.
In the patients with prolonged sympathetic nerve recordings, changes in sympathetic activity closely paralleled the changes in calf vascular resistance during (a) nonhypotensive hemodialysis, (b) hemodialysis-induced hypotension, and (c) reinfusion of blood after hemodialysis (Fig. 2) .
Plasma norepinephrine did not change significantly from the start to the end ofhemodialysis in either hypotension-resistant patients (from 613±117 to 657±140 pg/ml) or in hypotension-prone patients (from 525±68 to 591±23 pg/ml). Plasma epinephrine was unchanged during hemodialysis in the hypotension-resistant patients (from 83±18 to 96±53 pg/ml) but increased during hemodialysis-induced hypotensive episodes in the three patients in whom it was measured (from 52±9 to 143±53 pg/ml).
In the hypotension-prone patients, hemodialysis was accompanied by progressive reductions in left ventricular endsystolic dimension, which approached cavity obliteration before the onset of the hypotensive episodes ( Fig. 3 and Table  III ). In the hypotension-resistant patients, however, hemodialysis was not accompanied by significant changes in left ventricular dimensions.
In both groups ofpatients, hemodialysis produced no echocardiographic or electrocardiographic evidence of myocardial ischemia, even during the hypotensive episodes. Fig. 4 shows the calf vascular responses to three different hemodialysis maneuvers. Ultrafiltration alone, without dialysis, reproduced both the increases in calfresistance that accompany nonhypotensive hemodialysis and the sudden decreases in calf resistance that accompany hemodialysis-induced hypotension. In contrast, dialysis alone, without ultrafiltration, had no effect on calf vascular resistance.
Responses to tests ofbaroreflexfunction. Normal baroreflex control ofmuscle sympathetic nerve activity was demonstrated by the observations that sympathetic activity: (a) exhibited normal cardiac rhythmicity (i.e., the minimum interburst interval equals the cardiac cycle length) in each ofthe 16 patients in whom it was measured (Fig. 5) ; (b) increased abruptly with the sharp fall in blood pressure produced by spontaneous extrasystoles (nine patients) (Figs. 5 and 6), and (c) increased normally during phases II and III of the Valsalva maneuver and decreased upon its release (phase IV) (Fig. 6) . During phases II and III of the Valsalva maneuver, muscle sympathetic activity increased from 782±100 to 2,302±330 U (P < 0.05) while cardiac cycle length decreased from 794±36 to 700±31 ms (P < 0.05), while during phase IV, muscle sympathetic activity decreased to 425±88 U (P < 0.05 vs. baseline) and cardiac cycle length returned to baseline (834±44 ms).
Forearm vascular resistance increased normally during unloading of cardiopulmonary baroreceptors with graded lower body negative pressure in both hypotension-prone and -resistant hemodialysis patients (Table IV) .
Heart rate increased normally in both groups of patients during unloading ofarterial baroreceptors with graded intravenous infusion of nitroprusside (Fig. 7) .
Discussion
The data in this study provide the first direct measurements of sympathetic nerve activity and regional vascular resistance during hemodialysis. The principal new conclusion is that, in a group of hemodialysis patients without diabetes mellitus or other conditions known to impair autonomic reflexes, hemodialysis-induced hypotension is not caused by a chronic uremic impairment of arterial or cardiopulmonary baroreflexes but In addition to patient selection criteria, which were more narrowly defined in this than in most previous studies, there are other important methodologic differences between our study and the previous studies suggesting that chronic uremic impairment of the afferent arm of the arterial baroreflex is an important cause of hemodialysis-induced hypotension (4-9). First, whereas previous conclusions were derived mainly from nonspecific, semiquantitative autonomic function tests, the use of more specific and quantifiable reflex maneuvers allowed us to conclude that chronic uremia per se does not attenuate a number of specific reflexes, including arterial baroreflex control of heart rate and cardiopulmonary baroreflex control of vascular resistance. Second, we performed our neurocirculatory studies during actual sessions of hemodialysis as well as during the interdialysis period, allowing us to separate the autonomic effects of chronic uremia (which were undetectable) from those of acute hemodialysis (which were profound).
An important feature of this study is the demonstration of surprisingly normal baroreflex function in patients with chronic uremia, even in those with a history ofdialysis-induced hypotension. This interpretation, which is consistent with and extends recent observations by Nakashima et al. ( 11) , is based upon multiple lines of evidence. Heart rate, for example, increased normally during decreases in blood pressure produced by nitroprusside, documenting normal arterial baroreflex control of heart rate in hypotension-prone as well as in hypotension-resistant dialysis patients. In the hypotension-prone patients, the arterial baroreflex also functioned normally during hemodialysis since, before the onset of severe proportionate increase in heart rate. However, recent data suggest that preservation ofbaroreflex control ofheart rate cannot necessarily be taken to indicate preservation ofbaroreflex control of peripheral sympathetic nerve activity and vascular resistance (22) , which is more important than heart rate in the reflex regulation of arterial pressure. We subsequently addressed this issue using microelectrode recordings of muscle sympathetic nerve activity together with corresponding measurements of regional vascular resistance.
Because the "restless legs syndrome" (21 ) In this patient, the onset of hemodialysis-induced hypotension was preceded by a small decrease in end-diastolic dimension and a marked decrease in end-systolic dimension, the latter approaching left ventricular cavity obliteration.
increase in sympathetic nerve activity evoked by a given decrease in arterial pressure (i.e., baroreflex gain) and therefore cannot exclude the possibility that chronic uremia and a history ofdialysis-induced hypotension might be accompanied by a subtle attenuation of arterial baroreflex control of muscle sympathetic nerve activity. However, the findings that the sympathetic activity not only retained its normal cardiac rhythmicity in all of our dialysis patients but also increased with each decrease in blood pressure evoked by spontaneous extrasystoles and increased markedly with the Valsalva maneuver exclude the possibility of complete sinoaortic denervation (23, 24) and support the conclusion that a major impairment in baroreflex control of sympathetic nerve activity is not a necessary consequence of chronic uremia. The lack ofan increase in heart rate during nonhypotensive hemodialysis should not be interpreted as indicating a selective impairment in the baroreflex regulation of sympathetic outflow to the heart. During nonhypotensive hemorrhage (simulated by nonhypotensive lower body negative pressure), an increase in peripheral vascular resistance without an increase in heart rate is the expected pattern of reflex response to unloading of mainly "low pressure" cardiopulmonary, rather than "high pressure" arterial, baroreceptors (20) .
In the subset of patients in whom sympathetic nerve activity was recorded continuously throughout most ofthe hemodialysis period, the parallel changes in sympathetic activity and Indeed, during the mild decreases in blood pressure observed before the onset of frank dialysis-induced hypotension, the progressive increases in heart rate, vascular resistance, and efferent sympathetic activity were most likely caused by a progressive reduction in inhibitory afferent baroreceptor input to the vasomotor center. If uremic poisoning of these afferent nerves had caused baroreceptor activity to be substantially reduced under basal conditions and thus could not decrease much further during hemodialysis-induced hypotension, it follows that efferent sympathetic nerve activity should have in- (25) .
Our experiments in which we divided the usual hemodialysis procedure (dialysis plus ultrafiltration) into its component parts (dialysis alone and ultrafiltration alone) strongly suggest that hypovolemia per se, rather than changes in the uremic milieu (e.g., ion shifts which might be expected to alter baroreceptor discharge) (26), is the primary stimulus that triggers this vasodepressor reaction. This interpretation is consistent with an increasing body of experimental evidence that the abrupt withdrawal of sympathetic activation, with bradycardia and vasodilation, is a predictable autonomic response to hypovolemic hypotension (13) (14) (15) . In humans, hypotension with inappropriately normal or frankly decreased heart rate previously has been observed during hemorrhagic shock (27) , infusion of catecholamines during upright tilt (28) , and infusion of vasodilators, the latter being accompanied by a parallel decrease in muscle sympathetic nerve activity (29, 30) .
Although the precise underlying mechanisms causing hypovolemia-induced vasodepressor syncope are incompletely understood, the present data provide some important clues about the conditions required to trigger this reaction during hemodialysis. Such (32, 33) . Although opiate receptor blockade with naloxone has been shown to reverse hemorrhage-induced sympathoinhibition in conscious rabbits (32, 33) , it has not proven to be effective in treating hemorrhagic shock in humans (34) . Naloxone does not appear to prevent vasodepressor syncope during simulated orthostatic stress (35) , and in one of our patients did not prevent and may have exacerbated the acute hypotensive episode during hemodialysis.
The most widely accepted theory is that hypovolemia-induced vasodepressor syncope is caused by activation of cardiac afferents, located primarily in the inferoposterior wall of the left ventricle, triggering reflex inhibition of sympathetic outflow (36, 37) . Because of the high incidence of coronary artery disease in chronic hemodialysis patients (4, 38) , we considered the possibility that during hemodialysis cardiac afferents and reflex inhibition of sympathetic outflow might be activated by acute myocardial ischemia (39) . In our patients, however, this is an unlikely explanation for vasodepressor syncope because the hypotensive episodes were not accompanied by any electrocardiographic or echocardiographic evidence of myocardial ischemia.
Studies in laboratory animals have advanced the theory that during hypovolemic hypotension ventricular mechanoreceptor afferents are activated "paradoxically" by excessive deformation oftheir receptive fields when the adrenergically stimulated heart contracts forcefully around an almost empty ventricular chamber (36, 37) . Previous echocardiographic studies in patients have demonstrated that hemodialysis causes both decreased ventricular chamber size and increased ventricular contractility (40) , which are the necessary conditions for triggering paradoxical activation of ventricular mechanoreceptor afferents. Our echocardiographic demonstration that a marked reduction in left ventricular end-systolic dimension (approaching cavity obliteration) during hemodialysis preceded, rather than followed, the onset of vasodepressor syncope is consistent with this ventricular afferent hypothesis. However, multiple, redundant, and as yet unidentified mechanisms also may be involved ( 14, 30, (41) (42) (43) 
